Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
2019 · The Lancet Neurology · 624 citations
https://doi.org/10.1016/s1474-4422(19)30395-3
T
Thomas Leung
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
454
Papers
14.5K
Citations
64
h-index
223
i10-index
Thomas Leung is an academic researcher from Hong Kong Polytechnic University. The author has contributed to research in topics: Acute Ischemic Stroke Management & Cerebrovascular and Carotid Artery Diseases & Intracranial Aneurysms: Treatment and Complications. The author has an h-index of 64, co-authored 386 publications.
ORCID: 0000-0001-8193-0709Papers by this author
worksEndovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
2019 · The Lancet Neurology · 624 citations
https://doi.org/10.1016/s1474-4422(19)30395-3
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
2023 · The Lancet Neurology · 589 citations
https://doi.org/10.1016/s1474-4422(23)00277-6
Stroke
2024 · The Lancet · 433 citations
https://doi.org/10.1016/s0140-6736(24)00642-1
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
2019 · The Lancet Neurology · 182 citations
https://doi.org/10.1016/s1474-4422(19)30197-8
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
2021 · Neurology · 152 citations
https://doi.org/10.1212/wnl.0000000000011885
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat